With over 26,000 people employed in the sector in the Northwest, there is an extensive pool of local talent with specialist skills and experience. Bionow is particularly keen to assist member companies to access this rich resource of local talent.
Current vacancies and opportunities are listed below.
Premium Members and Members of Bionow can post vacancies online free of charge. These vacancies are then visible to all visitors to the Bionow website both local and from further afield. An animated website user guide is available here which demonstrates how members can add jobs directly to the website.
SRG - Bionow's Preferred Recruitment Partner
Guidance for posting jobs on the Bionow website
Eli Lilly and Company is a leading global pharmaceutical corporation, with a multi-billion dollar turnover and an international reputation for quality and innovation. Elanco is a division of Lilly and a world leader in the development of products and services that enhance animal health, wellness and performance. At our bulk manufacturing operations in Speke, Merseyside, we manufacture a range of animal health products predominantly through fermentation operations.
We are seeking an experienced analyst to join our lab team at our manufacturing site in Speke.
The MRC Centre for Drug Safety Science seeks an individual for an exciting and challenging role to progress pre-competitive interactions with the pharmaceutical industry.
You will need a strong scientific background in Pharmacology, having worked within in vitro pre-clinical drug development and with different types of assays for media throughput for lead optimisation.
Working as part of a new world-class team in drug development, you will be responsible for designing, creating and optimising novel drug candidates against a variety of cancer targets using the latest parallel technologies and purification techniques.
Working as part of a new world-class team in drug development, you will be responsible for designing, creating and optimising novel drug candidates against a variety of cancer targets using the latest parallel technologies and purification techniques.